Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery
This study has been completed.
Study NCT00082121   Information provided by Avant Immunotherapeutics
First Received: April 29, 2004   Last Updated: July 19, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Myocardial Ischemia
Coronary Arteriosclerosis
Aortic Valve Insufficiency
Mitral Valve Insufficiency
Additional conditions recognized in this trial
Arteriosclerosis
Coronary Artery Disease
Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Heart Valve Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
TP10
Sponsors listed in this trial
Avant Immunotherapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services